Optinose
Manufacturing · Pennsylvania, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
777 Township Line Rd Ste 300, Yardley, P...Phone Number
(267) 364-3500Website
www.optinose.comRevenue
$24.6 MillionStock Symbol
OPTNIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has offices in the U.S. and Norway.Explore more
Optinose Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Optinose your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Optinose had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Optinose has new funding data
Check out if Optinose is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Optinose
Optinose, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Optinose recently announced quarterly report
Check if Optinose has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Optinose launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Optinose as Masked Content
Find more new buyers
Compare Similar Companies to Optinose
Compare insights from companies similar to Optinose, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Optinose
$24.6M
51-200
Public
$630.7M
2010
RU
Robert UsellerVice President, Manufacturing & Supply Chain
Company Profile Activity
Activity Insights
Optinose is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Optinose is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Optinose.
Optinose financials insights
Gather financial insights about Optinose, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2002
Unspecified
$933K
2010
Private Equity
$48.5M
2014
Series C
$35M
2015
Other Financing Round
$30M
2017
Series D
$37M
Stock Offering
$138M
2018
Debt
$100M
Stock Offering
$52.3M
2019
Debt
$150M
Stock Offering
$39M
Optinose Tech Stack
A closer look at the technologies used by Optinose
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Person-Based
Optinose News & Media
OPTINOSE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of OptiNose, Inc. - OPTN
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of OptiNose, Inc. (NasdaqGS: OPTN) to Paratek Pharmaceuticals. Under the terms of the proposed transaction, shareholders of OptiNose will receive $9.00 per share in cash, plus up to $5.00 per share in contingent value rights payable in the event that certain net revenue milestonesBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: The AZEK Company Inc. (NYSE - AZEK), Mesa Air Group, Inc. (Nasdaq - MESA), Mr. Cooper Group Inc. (Nasdaq – COOP), Optinose, Inc. (Nasdaq - OPTN)
BALA CYNWYD, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.After Fielding Multiple Offers, Yardley-Based Optinose Secures Potential $330M Deal With Paratek
Yardley-based Optinose, which put itself up for auction 3 years ago, secures potential $330 million deal with Paratek.BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: The AZEK Company Inc. (NYSE - AZEK), Mesa Air Group, Inc. (Nasdaq - MESA), Mr. Cooper Group Inc. (Nasdaq – COOP), Optinose, Inc. (Nasdaq - OPTN)
BALA CYNWYD, Pa., April 08, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Optinose
Sign Up For FreeTo access detailed company insights
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has offices in the U.S. and Norway.... Read More
